יום שלישי, ה׳ אלול תשפ״וTuesday, August 18, 2026
Follow Us
By Jewish News Syndicate (JNS)
The Israel-based company’s shares will hit the market at a price of $21, raising some $861 million at a valuation of $16.7 billion.
“We believe that this transaction will yield important benefits for NeuroDerm’s shareholders and the Parkinson’s disease patients who urgently need new therapies."
Israel's Elbit Systems has racked up two more sales, this time by its cyber security subsidiary Cyberbit to a European police force and an African enforcement agency. Elbit, listed on NASDAQ, did not disclose the amount of the sales. It set up the Cyberbit subsidiary earlier this year to include the cyber and intelligence divisions […]
Teva Pharmaceutical is moving its global headquarters from Petach Tikva to Ra'anana, sources told the Globes business newspaper. The giant generic drugs company reputedly will pay $125 million for the land and new buildings on a site owned by Toyota's Israeli importer. Some of the land at Teva's current headquarters will be sold, and the […]
The U.S. Food and Drug Administration (FDA) has reported positive results in its Phase 2a trial of an oral insulin capsule produced by Israeli-based Oramed. The drug is for the treatment of Type 2 diabetes. The Phase 2b study will be carried out later this year, and Oramed also plans a Phase 2a study for […]
Kitov Pharmaceuticals accounted it plans to apply for listing on the NASDAQ exchange, joining Israel-based Teva and Kamada that are traded on Wall Street. Kitov is hoping for approval from the U.S. Food and Drug Administration (FDA) after its Phase III clinical trial of a combination drug for the treatment of hypertension and pain relief. […]
SodaStream is another Israeli miracle, so is that why the anti-Israel folks are so angry? Yes, but also it must really bug them that so many Arab Palestinians work in SodaStream factories, ignoring the haters' boycott demands.
August 14, 2026 
